57 authors.
Michael A KelbermanDepartment of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, CO, USA.
Ellen RodbergDepartment of Biology, University of Massachusetts Amherst, Amherst, MA, USA.
Ehsan ArabzadehEccles Institute of Neuroscience, John Curtin School of Medical Research, The Australian National University, Canberra, AUS.ORCID 0000-0001-9632-0735 Chloe J Bair-MarshallNeuroscience Institute, NYU Langone Medical Center, New York University, New York, New York, USA.ORCID 0000-0001-6458-3266 Craig W BerridgeDepartment of Psychology, University of Wisconsin-Madison, Madison, WI, USA.
Esther BerrocosoNeuropsychopharmacology and Psychobiology Research Group, Department of Neuroscience, School of Medicine, Biomedical Research and Innovation Institute of Cádiz (INiBICA), University of Cadiz, Cadiz, Spain.ORCID 0000-0003-0208-7472 Vincent Breton-ProvencherDepartment of Psychiatry and Neuroscience, Université Laval, Québec, QC, Canada.ORCID 0000-0002-1701-325X Alicia CheDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Oscar DavySchool of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom.
Anthony M DownsBowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0003-0146-4459 Gabrielle DrummondDepartment of Brain and Cognitive Sciences, Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID 0000-0001-9903-6211 Zeinab FazlaliSchool of Cognitive Sciences, Institute for Research in Fundamental Sciences (IPM), Tehran, Iran.ORCID 0000-0002-6728-2992 Robert C FroemkeNeuroscience Institute, NYU Langone Medical Center, New York University, New York, New York, USA.
Erin GlennonNeuroscience Institute, NYU Langone Medical Center, New York University, New York, New York, USA.
Hiroki ItoSchool of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom.ORCID 0000-0002-4433-370X Xiaolong JiangDepartment of Neuroscience, Baylor College of Medicine Neurological Research Institute at Texas Children's Hospital, 1250, Houston, TX, USA.
Joshua P JohansenRIKEN Center for Brain Science, Wako-shi Saitama, Japan.
Rong-Jian LiuDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Yang LiuDepartment of Biomedical Engineering, Columbia University, New York, NY, USA.
Meritxell Llorca-TorralbaNeuropsychopharmacology and Psychobiology Research Group, Department of Neuroscience, School of Medicine, Biomedical Research and Innovation Institute of Cádiz (INiBICA), University of Cadiz, Cadiz, Spain.ORCID 0000-0001-8447-928X Jordan G McCallDepartment of Anesthesiology, Washington University in St. Louis, St. Louis, MO, USA.ORCID 0000-0001-8295-0664 Zoe A McElligottBowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0002-4717-5698 Andrew M McKinneyDepartment of Neuroscience, Baylor College of Medicine Neurological Research Institute at Texas Children's Hospital, 1250, Houston, TX, USA.ORCID 0000-0003-4439-2264 Cristina MiguelezDepartment of Pharmacology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain.ORCID 0000-0001-6624-2932 Ming-Yuan MinDepartment of Life Science, College of Life Science, National Taiwan University, Taipei, Taiwan.ORCID 0000-0003-4211-6725 Alexandra C NowlanBowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0001-8543-119X Gina R PoeIntegrative Biology and Physiology, UCLA, Los Angeles, CA, USA.
Anthony Edward PickeringSchool of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom.ORCID 0000-0003-0345-0456 Yadollah Ranjbar-SlamlooSchool of Cognitive Sciences, Institute for Research in Fundamental Sciences (IPM), Tehran, Iran.
Jone RazquinDepartment of Pharmacology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain.ORCID 0000-0001-7996-7895 Charles RodenkirchDepartment of Biomedical Engineering, Columbia University, New York, NY, USA.
Anna C SalesSchool of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom.ORCID 0000-0001-8585-3763 Mriganka SurDepartment of Brain and Cognitive Sciences, Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID 0000-0003-2442-5671 John Arthur TkaczynskiDepartment of Neuroscience, Rowan-Virtua SOM, Stratford, NJ, USA.
Sonia Torres-SanchezNeuropsychopharmacology and Psychobiology Research Group, Department of Neuroscience, School of Medicine, Biomedical Research and Innovation Institute of Cádiz (INiBICA), University of Cadiz, Cadiz, Spain.ORCID 0000-0003-0255-6558 Akira UematsuHuman Informatics and Information Research Institute, National Institute of Advanced Industrial Science and Technology, Japan.ORCID 0000-0002-0679-2649 Chayla R VazquezDepartment of Anesthesiology, Washington University in St. Louis, St. Louis, MO, USA.ORCID 0000-0002-0077-9224 Amelien VrevenHelsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Barry D WaterhouseDepartment of Neuroscience, Rowan-Virtua SOM, Stratford, NJ, USA.
Hsiu-Wen YangDepartment of Biomedical Sciences, Chung-Shan Medical University, Taichung, Taiwan.
Jen-Hau YangDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Liping ZhaoDepartment of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA USA.
Ioannis S ZouridisGraduate Training Centre of Neuroscience, International Max Planck Research School (IMPRS), University of Tübingen, Tübingen, Germany.ORCID 0000-0002-4032-3723 David WeinshenkerDepartment of Human Genetics, Emory University, Atlanta, GA, USA.
Elena VazeyDepartment of Biology, University of Massachusetts Amherst, Amherst, MA, USA.
Nelson K TotahHelsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.ORCID 0000-0002-0998-9770 U19 Supplement 2023-FroemkeU19NS107616 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI RICHARD W TSIEN · 2018 to 2026
$36.4MSupplement to Molecular and Cellular Studies on Alcohol's ActionsT32AA007573 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FULTON T CREWS, Thomas L. Kash · 1997 to 2026
$9.3MSynaptic basis of perceptual learning with cochlear implants in rat auditory cortex - RenewalR01DC012557 · NIDCD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Robert Crooks Froemke, Mario A Svirsky · 2013 to 2026
$7.0MMicroRNA mechanisms of Rett SyndromeR01MH085802 · NIMH · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SUR, MRIGANKA · 2010 to 2025
$6.2MPDE5 Inhibition of Afferents and Interstitial Cells in Overactive Mouse BladdersR01DK098361 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BIRDER, LORI A, KANAI, ANTHONY JOHN · 2014 to 2024
$5.7M4/8: INIA Stress and Chronic Alcohol Interactions: Impact of stress mediated locus coeruleus dysregulation on cognitive control and excessive drinkingU01AA025481 · NIAAA · UNIVERSITY OF MASSACHUSETTS AMHERST · PI DAVID E MOORMAN, Elena Vazey · 2017 to 2026
$4.2MTraining In Systems And Integrative Biology NeuroscienceT32NS096050 · NINDS · EMORY UNIVERSITY · PI Yoland Smith · 2016 to 2026
$3.9MVISUAL SCIENCEST32EY007001 · NEI · BAYLOR COLLEGE OF MEDICINE · PI Samuel M Wu · 1985 to 2026
$3.7MDeciphering the building blocks of hippocampal circuitsR01MH109556 · NIMH · BAYLOR COLLEGE OF MEDICINE · PI SANDBERG, RICKARD, TOLIAS, ANDREAS · 2017 to 2021
$3.3MMechanisms underlying selective vulnerability of locus coeruleus neurons in Alzheimer's diseaseRF1AG061175 · NIA · EMORY UNIVERSITY · PI KANG, SEONG SU, WEINSHENKER, DAVID · 2019 to 2019
$2.8MNeuron-astrocyte mechanisms of norepinephrine in goal-directed learningR01MH133066 · NIMH · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI MRIGANKA SUR · 2023 to 2026
$2.6MEmotional modulation of neural and behavioral responses to social cues by locus coeruleusR01MH119250 · NIMH · COLD SPRING HARBOR LABORATORY · PI SHEA, STEPHEN D · 2019 to 2023
$2.4M